Cargando…

Cinnarizine/dimenhydrinate for vertigo

Detalles Bibliográficos
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	NPS MedicineWise 2021
Materias:	New Drugs
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8075741/ https://www.ncbi.nlm.nih.gov/pubmed/33911336 http://dx.doi.org/10.18773/austprescr.2021.009

Ejemplares similares

Cinnarizine and dimenhydrinate in the treatment of vertigo in medical practice
por: Scholtz, Arne-Wulf, et al.
Publicado: (2015)

Efficacy and Pharmacological Appropriateness of Cinnarizine and Dimenhydrinate in the Treatment of Vertigo and Related Symptoms
por: Plescia, Fulvio, et al.
Publicado: (2021)

Experimentally designed chromatographic method for the simultaneous analysis of dimenhydrinate, cinnarizine and their toxic impurities
por: Edrees, Fadwa H., et al.
Publicado: (2021)

Spectrofluorometric determination of orphenadrine, dimenhydrinate, and cinnarizine using direct and synchronous techniques with greenness assessment
por: Ghonim, Rana, et al.
Publicado: (2023)

Simultaneous estimation of dimenhydrinate, cinnarizine and their toxic impurities benzophenone and diphenylmethylpiperazine; in silico toxicity profiling of impurities
por: Abdelwahab, Nada S., et al.
Publicado: (2020)

Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study
por: Taghdiri, Foad, et al.
Publicado: (2014)

Efficacy and Safety of a Fixed-Dose Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg in the Treatment of Patients with Vestibular Vertigo: An Individual Patient Data Meta-Analysis of Randomised, Double-Blind, Controlled Clinical Trials
por: Scholtz, Arne W., et al.
Publicado: (2022)

Efficacy and Safety of a Fixed Combination of Cinnarizine 20 mg and Dimenhydrinate 40 mg vs Betahistine Dihydrochloride 16 mg in Patients with Peripheral Vestibular Vertigo: A Prospective, Multinational, Multicenter, Double-Blind, Randomized, Non-inferiority Clinical Trial
por: Scholtz, Arne W., et al.
Publicado: (2019)

Formulation and Characterization of Cinnarizine Targeted Aural Transfersomal Gel for Vertigo Treatment: A Pharmacokinetic Study on Rabbits
por: Abdelmonem, Rehab, et al.
Publicado: (2020)

Comparing the Effects of Epley Maneuver and Cinnarizine on Benign Positional Paroxysmal Vertigo; A Randomized Clinical Trial
por: Saeedi, Masoumeh, et al.
Publicado: (2019)

Development and Validation of RP-LC Method for the Determination of Cinnarizine/Piracetam and Cinnarizine/Heptaminol Acefyllinate in Presence of Cinnarizine Reported Degradation Products
por: EL-Houssini, Ola M., et al.
Publicado: (2013)

Siponimod for multiple sclerosis
Publicado: (2021)

Selexipag for pulmonary arterial hypertension
Publicado: (2021)

BNT162b2 vaccine for prevention of COVID-19
Publicado: (2021)

Defibrotide for hepatic veno-occlusive disease
Publicado: (2021)

Ozanimod for multiple sclerosis
Publicado: (2021)

ChAdOx1-S vaccine for prevention of COVID-19
Publicado: (2021)

Trifarotene for acne
Publicado: (2021)

Tafamidis and tafamidis meglumine for amyloid cardiomyopathy
Publicado: (2021)

Elexacaftor/tezacaftor/ivacaftor for cystic fibrosis
Publicado: (2021)

Recombinant varicella zoster virus glycoprotein E antigen vaccine for prevention of herpes zoster and postherpetic neuralgia
Publicado: (2021)

Trabectedin for soft tissue sarcoma
Publicado: (2021)

Sotrovimab for COVID-19
Publicado: (2021)

Elasomeran for prevention of COVID-19
Publicado: (2021)

Cariprazine hydrochloride for schizophrenia
Publicado: (2021)

Voretigene neparvovec for inherited retinal dystrophy
Publicado: (2021)

Lurbinectedin for small cell lung cancer
Publicado: (2021)

Esketamine hydrochloride for treatment-resistant depression
Publicado: (2021)

Satralizumab for neuromyelitis optica spectrum disorder
Publicado: (2021)

Lemborexant for insomnia
Publicado: (2021)

Zanubrutinib for mantle cell lymphoma, Waldenström’s macroglobulinaemia
Publicado: (2021)

Burosumab for X-linked hypophosphataemia
Publicado: (2021)

Trientine dihydrochloride for Wilson’s disease
Publicado: (2021)

Ripretinib for gastrointestinal stromal tumours
Publicado: (2021)

Romosozumab for osteoporosis
Publicado: (2021)

Niraparib for ovarian cancer
Publicado: (2021)

Axicabtagene ciloleucel for B-cell lymphoma
Publicado: (2021)

MYOCRISIN
Publicado: (1941)

Peramivir for influenza
Publicado: (2019)

Inotuzumab ozogamicin for acute lymphoblastic leukaemia
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hjobruqfi3unok0p49gn106dt1